Your session is about to expire
← Back to Search
This trial will test if a new drug can help reduce the size of polyps in people with a genetic disorder that causes them to grow.
- Familial Adenomatous Polyposis (FAP)
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is JNJ-64251330 a risk-free therapy for individuals?
"The safety rating of JNJ-64251330 is a 1 because this clinical trial is in its first phase, so there are limited data points to assess both efficacy and security concerns."
What is the objective of this investigation?
"This trial will measure the Percentage Change from Baseline in Colorectal Polyp Burden for all Polyps at Week 24 as its primary objective. Secondary outcomes include a report on the Percentage Change in Number of Rectal Polyps, the Change in Spigelman Stage Score (a classification system to assess risk of developing duodenal cancerr all Polyps at Week 24 as its primary objective. Secondary outcomes include a report on the Percentage Change in Number of Rectal Polyps, the Change in Spigelman Stage Score (a classification system to assess risk of developing duodenal cancer), and Percentage Change in Number of Duodenal Polyps."
What is the aggregate headcount for participants in this research project?
"In order to fully commence this medical study, 40 participants that meet the predetermined qualifications must join in. Potential candidates can be found at City of Hope situated in Duarte or Mayo Clinic located in Phoenix."
At what number of locations is this experimental endeavor taking place?
"6 medical facilities are participating in this trial, including City of Hope in Duarte, Mayo Clinic in Phoenix and University of Miami located also at Miami. Additionally, there are 6 other clinical sites that are partaking."
Are there still opportunities to participate in the research?
"Clinicaltrials.gov has revealed that this medical test is actively seeking participants since its inception on November 10th 2021. The trial was most recently updated on December 1st 2022."
Share this study with friends